Distinct Annular Oligomers Captured along the Assembly and Disassembly Pathways of Transthyretin Amyloid Protofibrils

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Pires, Ricardo H ^a,b   Karsai, Árpád ^c   Saraiva, Maria J ^b,d   Damas, Ana M ^b,d   Kellermayer, Miklós S Z ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY OF PÉCS   (Hungary)

^d UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; OLIGOMER; PREALBUMIN;

AMYLOID PROTOFIBRIL; AMYLOIDOSIS; ARTICLE; ATOMIC FORCE MICROSCOPY; CONFORMATIONAL TRANSITION; CYTOTOXICITY; IMAGE ANALYSIS; LIGHT SCATTERING; MOLECULAR IMAGING; PH; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS;

AMYLOID; AMYLOIDOSIS; HUMANS; HYDROGEN-ION CONCENTRATION; LIGHT; MICROSCOPY, ATOMIC FORCE; MODELS, MOLECULAR; PLAQUE, AMYLOID; PREALBUMIN; PROTEIN FOLDING; PROTEIN MULTIMERIZATION; RECOMBINANT PROTEINS; SCATTERING, RADIATION;

EID: 84866318129     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044992     Document Type: Article

References (54)

1. Stefani M (2012) Structural features and cytotoxicity of amyloid oligomers: Implications in Alzheimer's disease and other diseases with amyloid deposits. Prog Neurobiol: 10.1016/j.pneurobio.2012.1003.1002.
2. Jack CR Jr, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, et al. (2009) Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain 132: 1355-1365.
3. Demuro A, Smith M, Parker I, (2011) Single-channel Ca(2+) imaging implicates Abeta1-42 amyloid pores in Alzheimer's disease pathology. J Cell Biol 195: 515-524.
4. Capone R, Quiroz FG, Prangkio P, Saluja I, Sauer AM, et al. (2009) Amyloid-beta-induced ion flux in artificial lipid bilayers and neuronal cells: resolving a controversy. Neurotox Res 16: 1-13.
5. Last NB, Rhoades E, Miranker AD, (2011) Islet amyloid polypeptide demonstrates a persistent capacity to disrupt membrane integrity. Proc Natl Acad Sci U S A 108: 9460-9465.
6. Quist A, Doudevski I, Lin H, Azimova R, Ng D, et al. (2005) Amyloid ion channels: a common structural link for protein-misfolding disease. Proc Natl Acad Sci U S A 102: 10427-10432.
7. Pountney DL, Lowe R, Quilty M, Vickers JC, Voelcker NH, et al. (2004) Annular alpha-synuclein species from purified multiple system atrophy inclusions. J Neurochem 90: 502-512.
8. Kodali R, Wetzel R, (2007) Polymorphism in the intermediates and products of amyloid assembly. Curr Opin Struct Biol 17: 48-57.
9. Damas AM, Saraiva MJ, (2000) Review: TTR amyloidosis-structural features leading to protein aggregation and their implications on therapeutic strategies. J Struct Biol 130: 290-299.
10. Saraiva MJ, (1995) Transthyretin mutations in health and disease. Hum Mutat 5: 191-196.
11. Saraiva MJ, (2002) Hereditary transthyretin amyloidosis: molecular basis and therapeutical strategies. Expert Rev Mol Med 4: 1-11.
12. Westermark P, Sletten K, Johansson B, Cornwell GG 3rd (1990) Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci U S A 87: 2843-2845.
13. Saraiva MJ, (2001) Transthyretin mutations in hyperthyroxinemia and amyloid diseases. Hum Mutat 17: 493-503.
14. Lai Z, Colon W, Kelly JW, (1996) The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry 35: 6470-6482.
15. Pires RH, Saraiva MJ, Damas AM, Kellermayer MS, (2011) Structure and assembly-disassembly properties of wild-type transthyretin amyloid protofibrils observed with atomic force microscopy. J Mol Recognit 24: 467-476.
16. Colon W, Kelly JW, (1992) Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. Biochemistry 31: 8654-8660.
17. Quintas A, Saraiva MJ, Brito RM, (1997) The amyloidogenic potential of transthyretin variants correlates with their tendency to aggregate in solution. FEBS Lett 418: 297-300.
18. Barrera NP, Ormond SJ, Henderson RM, Murrell-Lagnado RD, Edwardson JM, (2005) Atomic force microscopy imaging demonstrates that P2X2 receptors are trimers but that P2X6 receptor subunits do not oligomerize. J Biol Chem 280: 10759-10765.
19. Carnally SM, Dev HS, Stewart AP, Barrera NP, Van Bemmelen MX, et al. (2008) Direct visualization of the trimeric structure of the ASIC1a channel, using AFM imaging. Biochem Biophys Res Commun 372: 752-755.
20. Kobori T, Smith GD, Sandford R, Edwardson JM, (2009) The transient receptor potential channels TRPP2 and TRPC1 form a heterotetramer with a 2:2 stoichiometry and an alternating subunit arrangement. J Biol Chem 284: 35507-35513.
21. Blake CC, Geisow MJ, Oatley SJ, Rerat B, Rerat C, (1978) Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 A. J Mol Biol. 121: 339-356.
22. Lashuel HA, Lansbury PT Jr, (2006) Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins? Q Rev Biophys 39: 167-201.
23. Liu K, Cho HS, Lashuel HA, Kelly JW, Wemmer DE, (2000) A glimpse of a possible amyloidogenic intermediate of transthyretin. Nature Structural Biology 7: 754-757.
24. Reixach N, Deechongkit S, Jiang X, Kelly JW, Buxbaum JN, (2004) Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture. Proceedings of the National Academy of Sciences of the United States of America 101: 2817-2822.
25. Sokolowski F, Modler AJ, Masuch R, Zirwer D, Baier M, et al. (2003) Formation of critical oligomers is a key event during conformational transition of recombinant syrian hamster prion protein. J Biol Chem 278: 40481-40492.
26. Sbrana F, Bongini L, Cappugi G, Fanelli D, Guarino A, et al. (2007) Atomic force microscopy images suggest aggregation mechanism in cerato-platanin. Eur Biophys J 36: 727-732.
27. Ding TT, Lee SJ, Rochet JC, Lansbury PT, (2002) Annular alpha-synuclein protofibrils are produced when spherical protofibrils are incubated in solution or bound to brain-derived membranes. Biochemistry 41: 10209-10217.
28. Ishimaru D, Andrade LR, Teixeira LSP, Quesado PA, Maiolino LM, et al. (2003) Fibrillar aggregates of the tumor suppressor p53 core domain. Biochemistry 42: 9022-9027.
29. Lashuel HA, Hartley DM, Petre BM, Wall JS, Simon MN, et al. (2003) Mixtures of wild-type and a pathogenic (E22G) form of A beta 40 in vitro accumulate protofibrils, including amyloid pores. Journal of Molecular Biology 332: 795-808.
30. Srinivasan R, Marchant RE, Zagorski MG, (2004) ABri peptide associated with familial British dementia forms annular and ring-like protofibrillar structures. Amyloid-Journal of Protein Folding Disorders 11: 10-13.
31. Malisauskas M, Zamotin V, Jass J, Noppe W, Dobson CM, et al. (2003) Amyloid protofilaments from the calcium-binding protein equine lysozyme: Formation of ring and linear structures depends on pH and metal ion concentration. Journal of Molecular Biology 330: 879-890.
32. Vendrely C, Valadie H, Bednarova L, Cardin L, Pasdeloup M, et al. (2005) Assembly of the full-length recombinant mouse prion protein I. Formation of soluble oligomers. Biochim Biophys Acta 1724: 355-366.
33. Diociaiuti M, Polzi LZ, Valvo L, Malchiodi-Albedi F, Bombelli C, (2006) Calcitonin forms oligomeric pore-like structures in lipid membranes. Biophysical Journal 91: 2275-2281.
34. Kumar S, Udgaonkar JB, (2009) Conformational conversion may precede or follow aggregate elongation on alternative pathways of amyloid protofibril formation. J Mol Biol 385: 1266-1276.
35. Orte A, Birkett NR, Clarke RW, Devlin GL, Dobson CM, et al. (2008) Direct characterization of amyloidogenic oligomers by single-molecule fluorescence. Proc Natl Acad Sci U S A 105: 14424-14429.
36. Ahmed M, Davis J, Aucoin D, Sato T, Ahuja S,et al. Structural conversion of neurotoxic amyloid-beta(1-42) oligomers to fibrils. Nat Struct Mol Biol 17: 561-567.
37. Carrotta R, Manno M, Bulone D, Martorana V, San Biagio PL, (2005) Protofibril formation of amyloid beta-protein at low pH via a non-cooperative elongation mechanism. J Biol Chem 280: 30001-30008.
38. Hill SE, Robinson J, Matthews G, Muschol M, (2009) Amyloid protofibrils of lysozyme nucleate and grow via oligomer fusion. Biophys J 96: 3781-3790.
39. Shahi P, Sharma R, Sanger S, Kumar I, Jolly RS, (2007) Formation of amyloid fibrils via longitudinal growth of oligomers. Biochemistry 46: 7365-7373.
40. Modler AJ, Fabian H, Sokolowski F, Lutsch G, Gast K, et al. (2004) Polymerization of proteins into amyloid protofibrils shares common critical oligomeric states but differs in the mechanisms of their formation. Amyloid 11: 215-231.
41. Modler AJ, Gast K, Lutsch G, Damaschun G, (2003) Assembly of amyloid protofibrils via critical oligomers-a novel pathway of amyloid formation. J Mol Biol 325: 135-148.
42. Mukhopadhyay S, Nayak PK, Udgaonkar JB, Krishnamoorthy G, (2006) Characterization of the formation of amyloid protofibrils from barstar by mapping residue-specific fluorescence dynamics. J Mol Biol 358: 935-942.
43. Yamaguchi I, Hasegawa K, Takahashi N, Gejyo F, Naiki H, (2001) Apolipoprotein E inhibits the depolymerization of beta 2-microglobulin-related amyloid fibrils at a neutral pH. Biochemistry 40: 8499-8507.
44. Blake C, Serpell L, (1996) Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous beta-sheet helix. Structure 4: 989-998.
45. Agocs G, Solymosi K, Varga A, Modos K, Kellermayer M, et al. (2010) Recovery of functional enzyme from amyloid fibrils. FEBS Lett 584: 1139-1142.
46. Cardoso I, Goldsbury CS, Muller SA, Olivieri V, Wirtz S, et al. (2002) Transthyretin fibrillogenesis entails the assembly of monomers: a molecular model for in vitro assembled transthyretin amyloid-like fibrils. J Mol Biol 317: 683-695.
47. Kelly JW, Colon W, Lai Z, Lashuel HA, McCulloch J, et al. (1997) Transthyretin quaternary and tertiary structural changes facilitate misassembly into amyloid. Adv Protein Chem 50: 161-181.
48. Kayed R, Pensalfini A, Margol L, Sokolov Y, Sarsoza F, et al. (2009) Annular protofibrils are a structurally and functionally distinct type of amyloid oligomer. J Biol Chem 284: 4230-4237.
49. Lasagna-Reeves CA, Glabe CG, Kayed R, (2011) Amyloid-{beta} Annular Protofibrils Evade Fibrillar Fate in Alzheimer Disease Brain. J Biol Chem 286: 22122-22130.
50. Stefani M, Dobson CM, (2003) Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J Mol Med (Berl) 81: 678-699.
51. Zheng J, Jang H, Ma B, Nussinov R, (2008) Annular structures as intermediates in fibril formation of Alzheimer Abeta17-42. J Phys Chem B 112: 6856-6865.
52. Zhu M, Han S, Zhou F, Carter SA, Fink AL, (2004) Annular oligomeric amyloid intermediates observed by in situ atomic force microscopy. J Biol Chem 279: 24452-24459.
53. Almeida MR, Damas AM, Lans MC, Brouwer A, Saraiva MJ, (1997) Thyroxine binding to transthyretin Met 119. Comparative studies of different heterozygotic carriers and structural analysis. Endocrine 6: 309-315.
54. Bryan RK, Fougere PF (1990) Maximum Entropy and Bayesian Methods. Kluwer Academic Publishers, The Netherlands: 221-232.